Introduction
============

White blood cell (WBC) or leukocyte count is a blood test used to detect a range of blood disorders, evaluate the severity of various underlying diseases, and at times predict the risk of death.[@b1-jbm-8-185]--[@b7-jbm-8-185] Several previous reports revealed a possible association between WBCs and severity of sickle cell disease (SCD).[@b7-jbm-8-185]--[@b10-jbm-8-185] Buchanan and Glader[@b11-jbm-8-185] reported that WBC counts were significantly increased during serious bacterial infection and vaso-occlusive crisis among children with SCD.

Litos et al[@b10-jbm-8-185] found that SCD patients who developed complications had higher WBC counts than asymptomatic SCD patients.[@b10-jbm-8-185] WBC count was found to be an accurate test for detecting acute chest syndrome in SCD patients who attended an emergency department (ED) with pain crises.[@b12-jbm-8-185] Castro et al[@b13-jbm-8-185] noted that WBC count was associated with acute chest syndrome in patients with SCD. Liem et al[@b14-jbm-8-185] reported SCD patients with acute chest syndrome had a higher WBC count compared to controls.

Evidence was found that a high level of WBC count is recognized as a major risk factor for hospital admission and frequent ED visits.[@b15-jbm-8-185],[@b16-jbm-8-185] Olatunji and Davies[@b15-jbm-8-185] documented that patients with particularly high levels of WBCs had frequent hospital admission. Recently, Curtis et al[@b16-jbm-8-185] found that an elevated WBC count was associated with high risk of frequent ED visits.

The evidence of the association between WBC and the severity of SCD mainly comes from epidemiological studies in Western countries; however, these findings may not be generalizable to SCD patients in non-Western countries. For better understanding, the role of WBCs in SCD severity should be assessed in various SCD populations worldwide, particularly in non-Western countries.

Studies in the Eastern Province of Saudi Arabia reported high WBC counts in Saudi children with SCD and acute chest syndrome,[@b17-jbm-8-185],[@b18-jbm-8-185] and another study assessed SCD complications in Saudi adults with SCD, revealing high WBC levels with a mean of 12.7×10^9^ cells/L.[@b19-jbm-8-185] Despite clear evidence that WBC was found to be associated with complications and poor prognosis in SCD patients, no study in the Saudi SCD population has been found to assess the prevalence of high WBCs and SCD severity or complications. The purpose of the current study was to estimate the prevalence of abnormal WBCs (low or high) and identify the predictors of high WBCs in a sample of Saudis with SCD, and severity of SCD. We hypothesize that SCD symptoms and complications may be associated with high WBCs in Saudi patients with SCD.

Methods
=======

Cross-sectional and retrospective designs were used to recruit and review medical charts of Saudi patients with SCD (age ≥2 years) who attended the outpatient clinic at King Fahad Hospital in Hofuf, Eastern Region, Saudi Arabia, for routine health assessment. Four hundred SCD patients attended King Fahad Hospital in Hofuf for routine assessment during the study period between October 1, 2016 and March 31, 2017. Of those, 290 consented and enrolled in the study, with a response rate of 72.5%.

The study included two stages: structured interview by a hematologist, and a chart review covering the previous 6 months for each patient. The interview took 10 to 15 min and the patients were asked to report whether they had fever, shortness of breath, cough, tiredness, wheezing, skin redness, swelling in hands/feet, blood transfusion, itching, and frequent (≥3) ED visits during the previous 6 months. Participants were asked whether they experienced frequent pain in the previous 6 months. Those who responded that they "experienced frequent pain" were asked to specify the pain site: back, arm, leg, and/or chest. Participants were allowed to select more than one pain site. If the participants were aged between 2 and 17 years, pain history was assessed by the child and/or the parents.

The medical chart of each patient was reviewed for the previous 6 months. We collected data on heart rate and blood tests. The blood tests included: hemoglobin, hemoglobin F, hemoglobin A2, hemoglobin S, and the WBC count. In case of multiple readings, the most recent reading was extracted. The WBC counts were assessed by automated blood cell counters (Beckman Coulter, Brea, CA, USA) and cell counts were expressed in 10^9^ cells/L. In order to estimate the prevalence of abnormal leukocyte count, we categorized leukocyte count into three groups: low \<4×10^9^ cells/L (low WBC count referred to a leukopenia), normal 4--11×10^9^ cells/L, and high \>11×10^9^ cells/L (high WBC count referred to a leukocytosis). The normal WBC range (4--11×10^9^ cells/L) was applied to all age groups. For the purpose of multivariate analysis, patients with low WBC counts were excluded to identify the independent predictors of high WBC counts.

Statistical analysis
====================

The analyses were performed using IBM SPSS Statistics for Windows, version 24 (IBM Corporation, Armonk, NY, USA). The sample characteristics were presented as percentages for non-numerical variables ([Table 1](#t1-jbm-8-185){ref-type="table"}) and counts and means and SDs for numerical variables ([Table 2](#t2-jbm-8-185){ref-type="table"}). We estimated the prevalence of abnormal leukocyte count (either low or high) using the percentage and 95% CIs. For subgroup analyses we used a chi-square test to assess the association between WBC groups and non-numerical variables ([Table 1](#t1-jbm-8-185){ref-type="table"}). For subgroup analyses we used the ANOVA test to assess the association between WBC groups and numerical variables ([Table 2](#t2-jbm-8-185){ref-type="table"}). In the adjusted analysis, we only considered high vs. normal WBC counts. Multiple-binary logistic regression was used to identify the independent factors associated with high WBC counts ([Table 3](#t3-jbm-8-185){ref-type="table"}). The aOR and 95% CIs were used to assess the strength of the relationship. The significant levels criterion was *P*\<0.05 in all analyses.

Ethics approval
===============

The Ethics Committee at the Saudi Ministry of Health approved this study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all patients included in the study. The study received ethical approval from the Saudi Ministry of Health (SMOH), Institutional Review Board Log No 15-247E. Verbal informed consent was approved by SMOH. The study research team obtained verbal consent from adult patients (age ≥18 years), while verbal consent was obtained from children's parents.

Results
=======

A total of 290 SCD patients were included in the analysis. The average age of the sample was 29.1 years (±SD=10.2) and the average WBC count was 10.7 (±SD=6.3). Slightly more than half of the patients, 159 (54.8%), were within the normal range of the leukocyte count. Abnormal leukocyte count was found in 131/290 (45.2%; 95% CI: 39.35%-51.10%), low WBC in 15/290 (5.2%; 95% CI: 2.92%-8.39%), and high in 116/290 (40%; 95% CI: 34.32%-45.89%). Of the sample, 53.3% had fever, 52.4% had shortness of breath, and 23.2% had frequent ED visits during the previous 6 months. [Table 1](#t1-jbm-8-185){ref-type="table"} presents more details on the sample characteristics.

In the subgroup analyses ([Table 1](#t1-jbm-8-185){ref-type="table"}), the percentage of high WBC count was higher in SCD patients with shortness of breath (47.1% vs. 33.6%, *P*=0.022), tiredness (43.4% vs. 31.0%, *P*=0.039), swelling in hands/feet (46.5% vs. 37.0%, *P*=0.020), and back pain (46.8% vs. 27.9%, *P*=0.007).

Subgroup analyses in [Table 2](#t2-jbm-8-185){ref-type="table"} show that the mean hemoglobin was higher in patients with normal WBC (low 8.7, normal 9.4, and high 8.9, *P*=0.024). The mean hemoglobin F was higher in patients with low WBC counts (low 18.8, normal 17.3, and high 14.5, *P*=0.001) ([Figure 1](#f1-jbm-8-185){ref-type="fig"}). The mean hemoglobin S was higher in patients with high WBC counts (low 76.9, normal 78.3, and high 81.1, *P*=0.003) ([Figure 2](#f2-jbm-8-185){ref-type="fig"}).

We identified multiple factors associated with high WBC counts compared to normal WBC counts (excluding low WBC counts) in [Table 3](#t3-jbm-8-185){ref-type="table"}. Male gender (aOR=3.63, 95% CI, 1.783−7.384) and patients with cough (aOR=2.18, 95% CI, 1.084−4.378) increased the odds of high WBCs. However, the odds of high WBCs tended to decrease by 24% for every unit increase in hemoglobin (aOR=0.76, 95% CI, 0.596--0.969), and by 3% for every unit increase in high heart rate (aOR=0.97, 95% CI, 0.936--0.997).

Discussion
==========

This epidemiological study was conducted to estimate the prevalence of abnormal leukocyte count (low or high) in a sample of Saudi patients with SCD, who were recruited from routine visits at King Fahad Hospital in Hofuf in the Eastern Province of Saudi Arabia where the prevalence of SCD was reported to be high.[@b20-jbm-8-185],[@b21-jbm-8-185] The study documented that high prevalence of abnormal leukocyte count was found in 131 (45.2%) of our total sample: low in 15 (5.2%), and high in 116 (40%). The study estimated the mean WBC counts of 10.7±6.3 (range =2.5--61) ×10^9^ cells/L. This finding was consistent with a study conducted on Saudi adults with SCD from the Eastern Province 12.7±7.6 (range =2.6--52.5) ×10^9^ cells/L.[@b19-jbm-8-185] However, their typical WBC value was higher than the average normal range (4--11×10^9^ cells/L). The high WBC counts in the SCD population could be as a result from infections or reactions to medications.[@b22-jbm-8-185],[@b23-jbm-8-185] Evaluation of WBCs should be performed periodically in primary health care clinics to identify patients with lower or higher values than the normal WBC range. This may enable hematologists to assess the current medications, underlying etiology, or impending SCD crisis and initiate treatment to mitigate symptoms and modifiable factors that are associated with high WBCs.

The male gender was independently associated with high WBC counts. The odds of high WBC counts were 3.6 times higher in males compared to females (aOR =3.63). As per the authors' knowledge, gender's effect on high WBC counts has not been documented in SCD patients. Influence of gender on WBC counts in SCD patients should be investigated in various SCD populations.

The prevalence of high WBC counts differs significantly between SCD patients with a cough and those with no cough. The odds of high WBC counts were 2 times higher in SCD patients with a cough than SCD patients with no cough. This finding is consistent with several studies.[@b24-jbm-8-185],[@b25-jbm-8-185] Eisenbrown et al[@b25-jbm-8-185] reported that a higher WBC level in SCD patients with a cough should prompt a chest X-ray.

According to subgroup analyses, there was a significant association between swelling in hands/feet and high WBC counts. Patients with swelling in hands/feet tend to have 2 times increased odds of high WBC compared to patients with no swelling in hands/feet. Several studies have shown that the presence of swelling in hands/feet in SCD patients was common, but they have not investigated its link with high WBC counts.[@b26-jbm-8-185],[@b27-jbm-8-185]

The high prevalence of cough and swelling in hands/feet in the SCD population could be targeted in future research to identify whether they are risk factors or symptoms of high WBCs.

The current study has demonstrated that hemoglobin and heart rate are negatively associated with high risk of high WBC counts. Routine examination of hemoglobin and heart rate to monitor WBC counts may help control SCD and its symptoms.

Limitations
===========

Several limitations can be highlighted in this study. The findings of the study result from cross-sectional and retrospective chart review, thus relationships may not represent causation. The study recruited SCD patients who attended a single hospital in Saudi Arabia for routine medical check-ups, thus the population may not be a good representation of the SCD population in Saudi Arabia. Despite several limitations, the study has findings that may serve as novel evidence in identifying the potential predictors of high WBCs.

Conclusion
==========

Abnormal leukocyte count was common: approximately five in ten Saudi SCD patients who were treated routinely at King Fahad Hospital in Hofuf. Male gender, cough, low hemoglobin, and low heart rate were associated with high WBC count. Strategies targeting high WBC count could prevent disease complication and thus be beneficial for SCD patients.
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###### 

WBC count and its relation to sample characteristics in SCD patients

  Characteristics          Levels   Overall N=290   Low \<4 15 (5.2%)   Normal 4--11 159 (54.8%)   *P*-value                 
  ------------------------ -------- --------------- ------------------- -------------------------- ----------- ------ ------ -------------------------------------------------
  Gender                   Female   131             45.2                7                          5.3         81     61.8   0.073
  Male                     159      54.8            8                   5.0                        78          49.1          
  Age, years               \<25     99              35.1                5                          5.1         57     57.6   0.397
  25--36                   123      43.6            6                   4.9                        66          53.7          
  \>36                     60       21.3            2                   3.3                        32          53.3          
  Fever                    No       133             46.7                6                          4.5         78     58.6   0.573
  Yes                      152      53.3            9                   5.9                        80          52.6          
  Cough                    No       152             52.4                9                          5.9         91     59.9   0.105
  Yes                      138      47.6            6                   4.3                        68          49.3          
  Shortness of breath      No       152             52.4                6                          3.9         95     62.5   0.022[\*](#tfn1-jbm-8-185){ref-type="table-fn"}
  Yes                      138      47.6            9                   6.5                        64          46.4          
  Wheezing                 No       232             82.6                15                         6.5         126    54.3   0.186
  Yes                      49       17.4            0                   0.0                        28          57.1          
  Tiredness                No       84              29.1                2                          2.4         56     66.7   0.029[\*](#tfn1-jbm-8-185){ref-type="table-fn"}
  Yes                      205      70.9            13                  6.3                        103         50.2          
  Swelling in hands/feet   No       200             69.9                7                          3.5         119    59.5   0.020[\*](#tfn1-jbm-8-185){ref-type="table-fn"}
  Yes                      86       30.1            8                   9.3                        38          44.2          
  Redness                  No       253             87.5                12                         4.7         140    55.3   0.661
  Yes                      36       12.5            3                   8.3                        19          52.8          
  Itching                  No       208             72.7                12                         5.8         118    56.7   0.292
  Yes                      78       27.3            3                   3.8                        38          48.7          
  Blood transfusion        No       196             67.6                10                         5.1         104    53.1   0.651
  Yes                      94       32.4            5                   5.3                        55          58.5          
  Back pain                No       104             35.9                7                          6.7         68     65.4   0.007[\*](#tfn1-jbm-8-185){ref-type="table-fn"}
  Yes                      186      64.1            8                   4.3                        91          48.9          
  Leg pain                 No       72              24.8                3                          4.2         32     44.4   0.075
  Yes                      218      75.2            12                  5.5                        127         58.3          
  Arm pain                 No       180             62.1                9                          5.0         98     54.4   0.962
  Yes                      110      37.9            6                   5.5                        61          55.5          
  Chest pain               No       176             60.7                7                          4.0         101    57.4   0.372
  Yes                      114      39.3            8                   7.0                        58          50.9          
  Frequent ED visits       No       199             76.8                11                         5.5         110    55.3   0.626
  Yes                      60       23.2            2                   3.3                        31          51.7          

**Note:**

Significant at α=0.05.

**Abbreviations:** WBC, white blood cell; SCD, sickle cell disease; ED, emergency department.

###### 

Differences in hemoglobin electrophoresis by WBC count

  Measure         Overall N=290   Low \<4 15 (5.2%)   Normal 4--11 159 (54.8%)   High \>11 116 (40%)   *P*-value                        
  --------------- --------------- ------------------- -------------------------- --------------------- ----------- ------ ------ ------ -------------------------------------------------
  Hemoglobin      9.2             1.5                 8.7                        1.3                   9.4         1.5    8.9    1.6    0.024[\*](#tfn3-jbm-8-185){ref-type="table-fn"}
  Heart rate      84.3            11.1                85.6                       10.3                  85.1        11.4   83.2   10.8   0.383
  Hemoglobin F    16.3            6.9                 18.8                       7.4                   17.3        7.1    14.5   6.3    0.001[\*](#tfn3-jbm-8-185){ref-type="table-fn"}
  Hemoglobin A2   3.3             1.3                 3.1                        1.2                   3.3         1.5    3.3    1.1    0.917
  Hemoglobin S    79.4            7.4                 76.9                       6.4                   78.3        7.4    81.1   7.2    0.003[\*](#tfn3-jbm-8-185){ref-type="table-fn"}

**Note:**

Significant at α=0.05.

**Abbreviation:** WBC, white blood cell.

###### 

Factors associated with high WBC count in SCD patients, N=275 (116 high and 159 normal)

  Factor                   B        SE      *P*-value                                         aOR    95% CI for OR   
  ------------------------ -------- ------- ------------------------------------------------- ------ --------------- -------
  Male                     1.289    0.363   0.001[\*](#tfn5-jbm-8-185){ref-type="table-fn"}   3.63   1.783           7.384
  Age 25--36 years         −0.418   0.389   0.283                                             0.66   0.307           1.412
  Age \>36 years           −0.249   0.435   0.567                                             0.78   0.332           1.829
  Fever                    0.159    0.339   0.638                                             1.17   0.604           2.277
  Cough                    0.779    0.356   0.029[\*](#tfn5-jbm-8-185){ref-type="table-fn"}   2.18   1.084           4.378
  Shortness of breath      0.025    0.395   0.949                                             1.03   0.473           2.222
  Wheezing                 −0.816   0.423   0.054                                             0.44   0.193           1.013
  Tiredness                0.220    0.396   0.579                                             1.25   0.573           2.708
  Swelling in hands/feet   0.641    0.398   0.107                                             1.90   0.870           4.138
  Redness                  −0.298   0.503   0.554                                             0.74   0.277           1.989
  Itching                  0.324    0.366   0.375                                             1.38   0.676           2.832
  Blood transfusion        −0.426   0.386   0.270                                             0.65   0.307           1.392
  Back pain                0.662    0.361   0.066                                             1.94   0.956           3.930
  Leg pain                 −0.934   0.383   0.015[\*](#tfn5-jbm-8-185){ref-type="table-fn"}   0.39   0.185           0.833
  Arm pain                 −0.057   0.336   0.865                                             0.94   0.489           1.825
  Chest pain               −0.110   0.348   0.751                                             0.90   0.453           1.770
  Frequent ED visits       0.185    0.408   0.651                                             1.20   0.541           2.674
  Hemoglobin               −0.274   0.124   0.027[\*](#tfn5-jbm-8-185){ref-type="table-fn"}   0.76   0.596           0.969
  Heart rate               −0.034   0.016   0.032[\*](#tfn5-jbm-8-185){ref-type="table-fn"}   0.97   0.936           0.997
  Hemoglobin F             0.009    0.037   0.814                                             1.01   0.938           1.084
  Hemoglobin A2            −0.022   0.128   0.863                                             0.98   0.762           1.256
  Hemoglobin S             0.034    0.031   0.273                                             1.03   0.973           1.100

**Note:**

Significant at α=0.05.

**Abbreviations:** aOR, adjusted odds ratio; CI, confidence interval; WBC, white blood cell; SCD, sickle cell disease; ED, emergency department.
